glucose 5%
Showing 26 - 50 of >10,000
Healthy Trial in Toronto (Control Cereal (no beta glucan), Cereal with oat beta glucan (OBG), Cereal with barely beta glucan
Not yet recruiting
- Healthy
- Control Cereal (no beta glucan)
- +2 more
-
Toronto, Ontario, CanadaINQUIS Clinical Research
Sep 26, 2022
Type 2 Diabetes, Inadequate Glucose Control Trial in Busan (duvie)
Completed
- Type 2 Diabetes Mellitus
- Inadequate Glucose Control
-
Busan, Korea, Republic ofPusan National University Hospital
Jan 4, 2022
End Stage Renal Disease Trial in Düsseldorf, Chieti (XyloCore Low Strenght, XyloCore Medium Strenght, XyloCore High Strenght,
Not yet recruiting
- End Stage Renal Disease
- XyloCore Low Strenght, XyloCore Medium Strenght, XyloCore High Strenght
- 1.36%, 1.5%, 2.27%, 2.5%, 3.86%, 2.25% Glucose PD Solution
-
Düsseldorf, Germany
- +1 more
Mar 28, 2022
Type 2 Diabetes Trial in Nanjing (Tirzepatide, Insulin Glargine)
Recruiting
- Type 2 Diabetes Mellitus
- Tirzepatide
- Insulin Glargine
-
Nanjing, Jiangsu, ChinaNanjing First Hospital
Sep 21, 2022
Insulin Resistance, Glucose Tolerance, Body Composition Trial in Basel (Eryhtritol, Sucrose)
Recruiting
- Insulin Resistance
- +3 more
- Eryhtritol
- Sucrose
-
Basel, Basel-Stadt, SwitzerlandSt. Claraspital
Oct 4, 2021
Kidney Transplant Recipients Trial in Toronto (Dapagliflozin 10 MG, Semaglutide, 1.0 mg/mL)
Not yet recruiting
- Kidney Transplant Recipients
- Dapagliflozin 10 MG
- Semaglutide, 1.0 mg/mL
-
Toronto, Ontario, CanadaToronto General Hospital
Jul 6, 2023
PERL Continuous Glucose Monitoring (CGM) Study
Completed
- Diabetic Nephropathies
- Mean blood glucose
- +10 more
-
Aurora, Colorado
- +18 more
Mar 28, 2022
End Stage Renal Disease Trial in Chieti (1.5% Xylitol, 0.5% Glucose, and 0.02% L-carnitine, 0.7% Xylitol, 0.5% Glucose, and
Recruiting
- End Stage Renal Disease
- 1.5% Xylitol, 0.5% Glucose, and 0.02% L-carnitine
- 0.7% Xylitol, 0.5% Glucose, and 0.02% L-carnitine
-
Chieti, ItalyDepartment of Nephrology, University of Chieti
Aug 20, 2021
Healthy Adults Trial in Toronto (Mixed-macronutrient meal)
Completed
- Healthy Adults
- Mixed-macronutrient meal
-
Toronto, Ontario, CanadaGoldring Center for High Performance Sport
Jan 18, 2022
Diabetes, Lipohypertrophy Trial in Vancouver (LH Protocol)
Not yet recruiting
- Diabetes Mellitus
- Lipohypertrophy
- LH Protocol
-
Vancouver, British Columbia, CanadaVancouver General Hospital Diabetes Centre
Oct 31, 2022
Type 1 Diabetes, Type 1 Diabetes With Hypoglycemia, Hypoglycemia Trial in Edinburgh (procedure, device, other)
Recruiting
- Type 1 Diabetes
- +5 more
- Stepped hyperinsulinaemic-hypoglycaemic clamp study
- +5 more
-
Edinburgh, United KingdomEdinburgh Royal Infirmary/University of Edinburgh
Jan 13, 2022
Diabetes, Lipohypertrophy Trial in Vancouver (Lipohypertrophy, Normal Subcutaneous Tissue)
Active, not recruiting
- Diabetes Mellitus
- Lipohypertrophy
- Lipohypertrophy
- Normal Subcutaneous Tissue
-
Vancouver, British Columbia, Canada
- +1 more
Sep 27, 2021
Blood Glucose Fluctuations, Hunger Trial in Vienna (Sucrose, Hesperetin)
Not yet recruiting
- Blood Glucose Fluctuations
- Hunger
- Sucrose
- Hesperetin
-
Vienna, AustriaChristian Doppler Laboratory for Taste Research
Jan 26, 2023
Healthy Aging, Healthy Diet Trial in Zürich (5min respiratory muscle exercises, 15min respiratory muscle exercises)
Recruiting
- Healthy Aging
- Healthy Diet
- 5min respiratory muscle exercises
- 15min respiratory muscle exercises
-
Zürich, ZH, SwitzerlandExercise Physiology Lab, Institute of Human Movement Sciences an
Dec 6, 2021
Total Knee Arthroplasty, Postoperative Oral Carbohydrates, Postoperative Recovery Trial (100ml carbohydrate containing 12.5g
Not yet recruiting
- Total Knee Arthroplasty
- +3 more
- 100ml carbohydrate containing 12.5g maltodextrin, fructose and glucose
- Routine feeding
- (no location specified)
Oct 30, 2022
Diabetes, Type 1 Trial in United Kingdom (Free Style Libre 2)
Completed
- Diabetes Mellitus, Type 1
- Free Style Libre 2
-
Poole, Dorset, United Kingdom
- +7 more
Aug 19, 2022
Type 2 Diabetes Treated With Insulin Trial (t:slim X2 insulin pump with Control-IQ technology 1.5 and Dexcom G6 CGM, Standard
Not yet recruiting
- Type 2 Diabetes Treated With Insulin
- t:slim X2 insulin pump with Control-IQ technology 1.5 and Dexcom G6 CGM
- Standard Therapy plus continuous glucose monitoring (CGM)
- (no location specified)
Mar 14, 2023
Urinary Retention, Colorectal Surgery, Rectal Resection Trial in Québec (pr Sandoz Tamsulosin, Glucose)
Not yet recruiting
- Urinary Retention
- +4 more
- pr Sandoz Tamsulosin
- Glucose
-
Québec, Que, Canada
- +1 more
Jul 4, 2023
Aneurysmal Subarachnoid Hemorrhage Trial in Innsbruck (Diben 1.5 kcal HP, Fresubin HP Energy Fibre (1.5 kcal))
Terminated
- Aneurysmal Subarachnoid Hemorrhage
- Diben 1.5 kcal HP
- Fresubin HP Energy Fibre (1.5 kcal)
-
Innsbruck, AustriaUniversitätsklinikum Innsbruck
Mar 15, 2022
Peritoneal Dialysis Complication, End Stage Kidney Disease, Sodium-glucose Co-transporter-2 Inhibitors Trial in Toronto
Not yet recruiting
- Peritoneal Dialysis Complication
- +4 more
- Empagliflozin 25 MG
-
Toronto, Ontario, CanadaToronto General Hospital
Jan 27, 2023
HbA1c Variation Study
Recruiting
- Diabetes Mellitus
- HBA1c data and glucose levels
-
Billings, Montana
- +10 more
Aug 2, 2022
Transesophageal Echocardiography, Acute Respiratory Distress Syndrome, Right Ventricular Dysfunction Trial in Wuhan
Not yet recruiting
- Transesophageal Echocardiography
- +2 more
- levosimendan
- 5% glucose injection
-
Wuhan, Hubei, ChinaUnion Hospital, Tongji Medical College, Huazhong University of S
Mar 12, 2023
Cardiac Surgical Procedures, Heart Valve Prosthesis Implantation Trial in Novosibirsk (Phosphocreatine sodium tetrahydrate after
Completed
- Cardiac Surgical Procedures
- Heart Valve Prosthesis Implantation
- Phosphocreatine sodium tetrahydrate after anaesthesia induction
- +7 more
-
Novosibirsk, Russian FederationEvgeny Fominskiy
Jun 28, 2021
Chronic Lymphocytic Leukemia Trial in Madison ([U-13C]glucose, [13C5]glutamine)
Recruiting
- Chronic Lymphocytic Leukemia
- [U-13C]glucose
- [13C5]glutamine
-
Madison, WisconsinUniversity of Wisconsin
Jun 15, 2022
Type 2 Diabetes, Non-Alcoholic Fatty Liver Disease, Obesity Trial in Leicester, Nottingham (Exercise)
Recruiting
- Type 2 Diabetes Mellitus
- +9 more
- Exercise
-
Leicester, East Midlands, United Kingdom
- +3 more
Mar 3, 2022